Neelis E G, Roskott A M, Dijkstra G, Wanten G J, Serlie M J, Tabbers M M, Damen G, Olthof E D, Jonkers C F, Kloeze J H, Ploeg R J, Imhann F, Nieuwenhuijs V B, Rings E H H M
Department of Pediatric Gastroenterology, University Medical Center Groningen, Beatrix Children's Hospital, Post Office Box 30.001, 9700 RB, Groningen, The Netherlands; Department of Pediatric Gastroenterology, Erasmus Medical Center-Sophia Children's Hospital, Post Office Box 2060, 3000 CB, Rotterdam, The Netherlands.
Department of Gastroenterology and Hepatology, University Medical Center Groningen, Post Office Box 30.001, 9700 RB, Groningen, The Netherlands.
Clin Nutr. 2016 Feb;35(1):225-229. doi: 10.1016/j.clnu.2015.01.010. Epub 2015 Jan 21.
BACKGROUND & AIMS: Exact data on Dutch patients with chronic intestinal failure (CIF) and after intestinal transplantation (ITx) have been lacking. To improve standard care of these patients, a nationwide collaboration has been established. Objectives of this study were obtaining an up-to-date prevalence of CIF and characterizing these patients using the specially developed multicenter web-based Dutch Registry of Intestinal Failure and Intestinal Transplantation (DRIFT).
Cross-sectional study. CIF was defined as type 3 intestinal failure in which >75% of nutritional requirements were given as home parenteral nutrition (HPN) for ≥ 4 weeks in children and >50% for ≥3 months in adults. All patients with CIF receiving HPN care by the three Dutch specialized centers on January 1, 2013 and all ITx patients were registered in DRIFT (https://drift.darmfalen.nl).
In total, 195 patients with CIF (158 adults, 37 children) were identified, of whom 184 were registered in DRIFT. The Dutch point prevalence of CIF was 11.62 per million (12.24 for adults, 9.56 for children) on January 1, 2013. Fifty-seven patients (31%) had one or more indications for ITx, while 12 patients actually underwent ITx since its Dutch introduction. Four patients required transplantectomy of their intestinal graft and 3 intestinal transplant patients died.
The multicenter registry DRIFT revealed an up-to-date prevalence of CIF and provided nationwide insight into the patients with CIF during HPN and after ITx in the Netherlands. DRIFT will facilitate the multicenter monitoring of individual patients, thereby supporting multidisciplinary care and decision-making.
一直缺乏关于荷兰慢性肠衰竭(CIF)患者及肠移植(ITx)后患者的确切数据。为改善这些患者的标准护理,已建立了全国性合作。本研究的目的是获取CIF的最新患病率,并使用专门开发的基于网络的多中心荷兰肠衰竭与肠移植登记系统(DRIFT)对这些患者进行特征描述。
横断面研究。CIF被定义为3型肠衰竭,即儿童中>75%的营养需求通过家庭肠外营养(HPN)给予≥4周,成人中>50%给予≥3个月。2013年1月1日,荷兰三个专业中心所有接受HPN护理的CIF患者以及所有ITx患者均在DRIFT(https://drift.darmfalen.nl)中进行登记。
共识别出195例CIF患者(158例成人,37例儿童),其中184例在DRIFT中登记。2013年1月1日,荷兰CIF的点患病率为百万分之11.62(成人12.24,儿童9.56)。57例患者(31%)有一项或多项ITx指征,自ITx在荷兰开展以来,有12例患者实际接受了ITx。4例患者需要切除肠道移植物,3例肠移植患者死亡。
多中心登记系统DRIFT揭示了CIF的最新患病率,并提供了荷兰全国范围内HPN期间及ITx后CIF患者的情况。DRIFT将有助于对个体患者进行多中心监测,从而支持多学科护理和决策制定。